Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) announced the completion of its merger with Synta Pharmaceuticals Corp. (Nasdaq: SNTA) (through July 22 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE